FFR para guiar la revascularización en SCA

FFR to Predict CABG Result: All Benefits in a Population Much Too Pure?

Coronary artery bypass graft (CABG) anastomosed to one vessel with normal or nearly normal fractional flow reserve (FFR) have poorer graft patency at one year compared against anastomosed grafts to vessels with functionally significant lesions shown by FFR. However, the recent study FARGO (Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization) did not show<a href="https://solaci.org/en/2019/08/16/ffr-to-predict-cabg-result-all-benefits-in-a-population-much-too-pure/" title="Read more" >...</a>

All You Need to Know About Bolivia Sessions 2019

After 2 years, SOLACI returns to Bolivia to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region. Are you planning on participating in the<a href="https://solaci.org/en/2019/08/14/all-you-need-to-know-about-bolivia-sessions-2019/" title="Read more" >...</a>

Estenosis aórtica severa asintomática en añosos: ¿cuándo intervenir?

How to Prevent Pharmacological Overtreating in the Elderly

Cardiovascular risk increases dramatically with over the years, which almost inevitable leads to treating the elderly with statins, based on risk. To prevent over treatment, we need to identify fragile patients (bed-ridden or with dementia), whose condition might make this treatment futile on the one hand, and on the other hand, patients who regardless their<a href="https://solaci.org/en/2019/07/26/how-to-prevent-pharmacological-overtreating-in-the-elderly/" title="Read more" >...</a>

ProEducar 2019 | We celebrate 10 Years of continuous interventional education!

The ProEducar Fellow Course is a special event designed for fellows or interventional trainees seeking to update their knowledge and perfect their skills on interventional cardiology. This intensive and quality event introduces four interventional modules focused on practice rather than theory, with step-by-step demonstrations, tips and secrets of the trade, and educational cases. The course<a href="https://solaci.org/en/2019/07/21/proeducar-2019-we-celebrate-10-years-of-continuous-interventional-education/" title="Read more" >...</a>

2019 Bolivia Sessions | Discover the Scientific Program

A most valuable event organized by SOLACI and the Bolivian Society of Cardiology (SOBOCAR) for all Latin American interventional cardiologists is almost upon us. The Bolivia Sessions will be held in Cochabamba, Bolivia, on August 23rd and 24th, 2019. This event will feature over 20 Latin American special guests and modules on: Acute coronary syndrome.<a href="https://solaci.org/en/2019/07/18/2019-bolivia-sessions-discover-the-scientific-program/" title="Read more" >...</a>

EuroPCR 2019 | Ultimo meta-análisis de TAVI, el espectro de tratamiento alcanza a todos los pacientes

EuroPCR 2019 | Most Recent TAVR Meta-Analysis: The Spectrum of Treatment Reaches All Patients

This new meta-analysis combines all randomized transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement trials and expands the scope of TAVR. Evidence across the range of risk studied supports a paradigm shift in patients with symptomatic severe aortic stenosis. The clinical superiority of TAVR compared with surgery has been demonstrated across the spectrum<a href="https://solaci.org/en/2019/05/30/europcr-2019-most-recent-tavr-meta-analysis-the-spectrum-of-treatment-reaches-all-patients/" title="Read more" >...</a>

$EuroPCR 2019 | Leaflex: nuevo dispositivo para fracturar el calcio pre TAVI$

EuroPCR 2019 | Leaflex: New Device for Pre-TAVR Calcium Fracture

Researchers behind this small study believe that fracturing the rigid calcium deposits on leaflets with this new device could delay the need for transcatheter aortic valve replacement (TAVR) or facilitate it. This device showed actual improvement of leaflet mobility together with mean gradient reduction. The Leaflex Performer system (Pi-Cardia) was used in 16 patients with<a href="https://solaci.org/en/2019/05/28/europcr-2019-leaflex-new-device-for-pre-tavr-calcium-fracture/" title="Read more" >...</a>

Double Kissing Crush vs. Provisional Stenting

Nonobstructive Coronary Lesions and Ventricular Dysfunction

Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction. Patients with heart failure are frequently<a href="https://solaci.org/en/2019/05/17/nonobstructive-coronary-lesions-and-ventricular-dysfunction/" title="Read more" >...</a>

Subclavian and Axillary Access for TAVR: a Valid Alternative

Courtesy of Dr. Carlos Fava. The femoral approach is preferred when it comes to TAVR, but sometimes it is not viable. This is when other access sites come into play, such as the trans-subclavian/axillary (TS/TAx), the apical, transcaval, transcarotid (TC) or transaortic. At present, few studies have looked into this matter, which is why it<a href="https://solaci.org/en/2019/04/11/subclavian-and-axillary-access-for-tavr-a-valid-alternative/" title="Read more" >...</a>

TAVI en insuficiencia aórtica pura, nuevos dispositivos con nuevos resultados

We Must Still Fear the “Big Five Complications” After TAVR

Surgical risk scores cannot be used for transcatheter aortic valve replacement (TAVR) and they usually overestimate procedural risk. There are 5 big complications after TAVR, specifically, that cannot be predicted by conventional surgical scores.   These 5 peri-procedural complications are considered important because they have a somewhat significant impact on survival after TAVR.   They are: 1)<a href="https://solaci.org/en/2019/04/01/we-must-still-fear-the-big-five-complications-after-tavr/" title="Read more" >...</a>